Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies

Clinical trial NCT06331117 · UNKNOWN

Trial details

NCT number: NCT06331117
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

RASopathy Costello Syndrome Noonan Syndrome Cardio-Facio-Cutaneous Syndrome

Start date: 2021-04-22
Primary completion: 2021-12-22
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.